YAAS · Youxin Technology Ltd

Current Thesis

Youxin Technology’s residual recovery case requires a weekly reclaim of $2.00 and a definitive RiverBit agreement before a weekly close below $1.00. This is a conditional reconstruction case: the previous floor thesis failed when the market closed at $1.39 on 2026-09-11, below the $2.00 weekly threshold published on 2026-08-30.

The narrative is dead — the 2026-09-11 close breached that threshold despite the revenue growth disclosed on 2026-08-27. That classification is an inference from the failed price condition, not a claim that the operating business has ceased. The company’s release and filing indexes, checked on 2026-09-13, still show 2026-08-27 as their latest disclosure date; no subsequent RiverBit launch confirmation was located there. Company releases, filing index.

Bullish and bearish views on Youxin Technology Ltd

The model's bull view on Youxin Technology Ltd (YAAS), in brief: Acquired operations generated reported revenue. The bear view: Revenue growth has not repaired losses. The six months ended 2026-03-31 produced a $1.93 million loss attributable to ordinary shareholders, versus $1.74 million a year earlier. Subscription revenue fell 8% to $0.09 million, limiting the evidence for a recurring software revenue… Both cases follow in full.

Bull Case

• Acquired operations generated reported revenue. For the six months ended 2026-03-31, revenue reached $1.88 million, increasing 444% year over year, and gross margin reached 41%. Management attributed growth principally to Celnet, acquired on 2025-10-29, alongside customized customer relationship management development services. 2026-08-27 results.
• Operating cash consumption decreased. Cash used in operations was $1.21 million for the six months ended 2026-03-31, versus $2.26 million in the comparable period. This measures improvement in cash consumption; it does not establish profitability. 2026-08-27 results.
• RiverBit consideration allows equity funding. The 2026-08-27 filing describes the 2026-07-14 non-binding proposal as up to $20 million for a 10% interest, payable in shares, cash or both. A cash-only funding interpretation is therefore incomplete; definitive agreements and operating milestones remain conditions. August filing.

Bear Case

• Revenue growth has not repaired losses. The six months ended 2026-03-31 produced a $1.93 million loss attributable to ordinary shareholders, versus $1.74 million a year earlier. Subscription revenue fell 8% to $0.09 million, limiting the evidence for a recurring software revenue expansion. 2026-08-27 results.
• Reported liquidity predates capital actions. Company cash was $4.55 million on 2026-03-31, compared with $9.91 million on 2025-09-30. That balance-sheet date precedes the 2026-06-25 at-the-market issuance agreement, so it does not establish current funding capacity. August filing.
• The published floor has failed. The adjusted market close of $1.39 on 2026-09-11 is below the prior research threshold of $2.00. Introducing a separate recovery test does not reverse that recorded invalidation.

Setup & Price Structure

The supplied adjusted series records a $1.39 close on 2026-09-11, a three-month decline of 69.4%, and a 14-period relative strength index (RSI) of 2.4. The same snapshot places the shares 96.7% below the $42.48 trailing annual high. These measurements establish severe weakness; they do not establish a reversal. Moving-average values and a confirmed base are absent from the available evidence.

The former $2.00 research threshold is now the recovery reference. The $1.00 level is a round-number boundary for the separate reconstruction case, not demonstrated support. Neither level describes a transaction.

Crowding evidence is limited to the supplied pre-market and after-market movers headlines dated 2026-08-31. That sample is too small to support a retail-crowding claim. On potential supply, the August filing documents an at-the-market program authorized on 2026-06-25 for up to $6,355,771; authorization alone does not establish subsequent issuance. Current short interest, borrow costs and insider transaction data are missing. August filing.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Fiscal year end. The company identifies September 30 as its fiscal year end. This closes an accounting period; it is not a confirmed results-release date. Company fiscal calendar.
• 2026-09-30 — Research review checkpoint. Prior coverage dated 2026-08-30 used month-end to assess RiverBit launch confirmation. It remains an editorial checkpoint, not a company-promised announcement or contractual deadline. The company indexes checked on 2026-09-13 contain no subsequent confirmation. Release index.

No company-confirmed earnings, product or transaction announcement date was located for 2026-09-13 through 2026-10-13. An unconfirmed launch cannot anchor a dated RiverBit milestone-expiry forecast.

What Would Change Our Mind

Failure to reconstruct the lost price floor would end the residual recovery case: a weekly close below $1.00 is its specific invalidation. Success requires both a weekly close above the former $2.00 threshold and a definitive RiverBit agreement disclosing consideration and funding, before that downside condition occurs. The 2026-07-14 non-binding proposal supplies the transaction reference; the 2026-09-11 close supplies the evidence for low conviction. Transaction disclosure.

A later cash report below the $4.55 million recorded on 2026-03-31, without disclosed financing, would weaken the funding case. Continued absence of a definitive agreement would leave the transaction component unfulfilled even if the price recovered.

Correlation Notes

This remains a single-name setup. The 2026-07-14 RiverBit proposal provides a prospective crypto-business connection, while the 2026-08-27 results document software and professional-services revenue. Neither establishes a measured relationship with cryptocurrency prices or broader software equities. No paired return series is supplied, so no correlation coefficient or group-led recovery claim is supported.